University of Maryland, Baltimore: Multiple Myeloma trials
The registry lists 11 Multiple Myeloma studies with University of Maryland, Baltimore as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 1 3Phase 2 8Phase 4 1No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple MyelomaTerminatedNCT04896658Phase 1/2Results posted
- 1068GCC Evaluate Efficacy & Explore Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy (BIPN) in Multiple MyelomaCompletedNCT01541644Not applicableResults posted
- Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor MobilizersWithdrawnNCT02682953Phase 2
- Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00049374Phase 2
- Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple MyelomaCompletedNCT00046852Phase 1/2
- Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00006350Phase 2
- Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationCompletedNCT00005946Phase 1
- Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple MyelomaCompletedNCT00003401Phase 2
- Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple MyelomaCompletedNCT00003399Phase 2
- Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003398Phase 4
- Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003396Phase 2